Regulation of VKORC1L1 is critical for p53-mediated tumor suppression through vitamin K metabolism
Cell Metabolism · 2023-08 · 35 (8) · 1474-1490.e8
DOI: 10.1016/j.cmet.2023.06.014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Metabolism, 2023-08. Verfasst von Xin Yang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Cancer Genetics, and Herbert Irving Comprehensive Cancer Center, Vagelos College of Physicians & Surgeons, Columbia University, New Yor…. Hauptthemen laut MEDLINE: Tumor Suppressor Protein p53, Warfarin. Die Arbeit wurde bisher 132-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIGMS NIH HHS, National Cancer Institute.
Abstract (Originalsprache)
Here, we identified vitamin K epoxide reductase complex subunit 1 like 1 (VKORC1L1) as a potent ferroptosis repressor. VKORC1L1 protects cells from ferroptosis by generating the reduced form of vitamin K, a potent radical-trapping antioxidant, to counteract phospholipid peroxides independent of the canonical GSH/GPX4 mechanism. Notably, we found that VKORC1L1 is also a direct transcriptional target of p53. Activation of p53 induces downregulation of VKORC1L1 expression, thus sensitizing cells to ferroptosis for tumor suppression. Interestingly, a small molecular inhibitor of VKORC1L1, warfarin, is widely prescribed as an FDA-approved anticoagulant drug. Moreover, warfarin represses tumor growth by promoting ferroptosis in both immunodeficient and immunocompetent mouse models. Thus, by downregulating VKORC1L1, p53 executes the tumor suppression function by activating an important ferroptosis pathway involved in vitamin K metabolism. Our study also reveals that warfarin is a potential repurposing drug in cancer therapy, particularly for tumors with high levels of VKORC1L1 expression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Cancer Genetics, and Herbert Irving Comprehensive Cancer Center, Vagelos College of Physicians & Surgeons, Columbia University, New York, NY, USA.
- Department of Chemistry, Columbia University, New York, NY, USA; Mass Spectrometry Core Facility, Columbia University, New York, NY, USA.
- Institute for Cancer Genetics, and Herbert Irving Comprehensive Cancer Center, Vagelos College of Physicians & Surgeons, Columbia University, New York, NY, USA; Department of Pediatrics, and Department of Genetics and D…
- Cell Biology Program, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
- Department of Chemistry, Columbia University, New York, NY, USA; Department of Biological Sciences, Columbia University, New York, NY, USA.
- Institute for Cancer Genetics, and Herbert Irving Comprehensive Cancer Center, Vagelos College of Physicians & Surgeons, Columbia University, New York, NY, USA; Department of Pathology and Cell Biology, Vagelos College…
Förderung
- NCI NIH HHS
- NIGMS NIH HHS
- National Cancer Institute
- National Institutes of Health
Zitieren
APA
Yang, X., Wang, Z., Zandkarimi, F., Liu, Y., Duan, S., Li, Z., Kon, N., Zhang, Z., Jiang, X., Stockwell, B. R., & Gu, W. (2023). Regulation of VKORC1L1 is critical for p53-mediated tumor suppression through vitamin K metabolism. Cell Metabolism, 35(8), 1474-1490.e8. https://doi.org/10.1016/j.cmet.2023.06.014
Vancouver
Yang X, Wang Z, Zandkarimi F, Liu Y, Duan S, Li Z, et al. Regulation of VKORC1L1 is critical for p53-mediated tumor suppression through vitamin K metabolism. Cell Metabolism. 2023;35(8):1474-1490.e8. doi:10.1016/j.cmet.2023.06.014
BibTeX
@article{Yang2023,
author = {Yang, Xin and Wang, Zhe and Zandkarimi, Fereshteh and Liu, Yanqing and Duan, Shoufu and Li, Zhiming and Kon, Ning and Zhang, Zhiguo and Jiang, Xuejun and Stockwell, Brent R and Gu, Wei},
title = {Regulation of VKORC1L1 is critical for p53-mediated tumor suppression through vitamin K metabolism},
journal = {Cell Metabolism},
year = {2023},
volume = {35},
number = {8},
pages = {1474--1490.e8},
doi = {10.1016/j.cmet.2023.06.014}
}
EUVIMED